TY - JOUR
T1 - Adjuvant high dose rate brachytherapy (Ir-192) in the management of keloids which have recurred after surgical excision and external radiation
AU - Garg, Madhur K.
AU - Weiss, Paul
AU - Sharma, Anand K.
AU - Gorla, Giridhar R.
AU - Jaggernauth, Wainwright
AU - Yaparpalvi, Ravindra
AU - DelRowe, John
AU - Beitler, Jonathan J.
PY - 2004/11/1
Y1 - 2004/11/1
N2 - We describe our experience with adjuvant high dose rate brachytherapy (Ir-192) (HDRB) in patients, who failed surgery and post-operative external radiation therapy. The salvage treatment consisted of excision of the keloid and wound closure followed by HDRB (15 Gy in three fractions given on three consecutive business days beginning the day of surgery). At the time of last follow up, 88% (15/17) of the keloids were without any evidence of recurrence.
AB - We describe our experience with adjuvant high dose rate brachytherapy (Ir-192) (HDRB) in patients, who failed surgery and post-operative external radiation therapy. The salvage treatment consisted of excision of the keloid and wound closure followed by HDRB (15 Gy in three fractions given on three consecutive business days beginning the day of surgery). At the time of last follow up, 88% (15/17) of the keloids were without any evidence of recurrence.
KW - High dose rate brachytherapy
KW - Keloids
KW - Salvage radiation therapy
UR - http://www.scopus.com/inward/record.url?scp=7944225346&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=7944225346&partnerID=8YFLogxK
U2 - 10.1016/j.radonc.2004.04.010
DO - 10.1016/j.radonc.2004.04.010
M3 - Article
C2 - 15542171
AN - SCOPUS:7944225346
SN - 0167-8140
VL - 73
SP - 233
EP - 236
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
IS - 2
ER -